(Q36611472)
Statements
Weekly administration of docetaxel in combination with estramustine and celecoxib in patients with advanced hormone-refractory prostate cancer: final results from a phase II study (English)
A Font
B Mellado
M Domenech
G Catalan
J Alfaro
A Gonzalez Del Alba
M Nogué
P Lianes
23 October 2007
1 reference
1 reference
1 reference